Status:
UNKNOWN
Preferred Reporting Items for Systematic Reviews and Meta-Analyses - Artificial Intelligence Extension
Lead Sponsor:
University of Southern California
Conditions:
Consensus Development
Eligibility:
All Genders
18+ years
Brief Summary
The investigators aim to develop the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Artificial Intelligence Extension (PRISMA-AI) guideline as a stand-alone extension of the PRISMA...
Detailed Description
With advances in artificial intelligence (AI) over the last two decades, enthusiasm and adoption of this technology in medicine have steadily increased. Yet despite the greater adoption of AI in medic...
Eligibility Criteria
Inclusion
- experts in the use AI technology in medicine
- experts in PRISMA
- leading authors of STARD-AI, CONSORT-AI, SPIRIT-AI, TRIPOD-AI, PROBAST-AI, CLAIM-AI and DECIDE-AI
Exclusion
- Panelists who were not able to commit to all rounds of the modified Delphi process will be excluded
Key Trial Info
Start Date :
June 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 15 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05382455
Start Date
June 15 2022
End Date
July 15 2022
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California
Los Angeles, California, United States, 90005